Elevated SPP1 expression has been observed in multiple cancers, such as CC colon cancer, lung cancer, prostate cancer, breast cancer, ovarian cancer, multiple myeloma, acute myeloid leukemia, and chronic myeloid leukemia [59–62]. This evidence concerns the gene SPP1 and chronic myelogenous leukemia, BCR-ABL1 positive.